<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Violan C</submitter><funding>Regional Ministry of Health of the Generalitat de Catalunya</funding><pagination>721</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9439943</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Understanding the immune response to the SARS-CoV-2 virus is critical for efficient monitoring and control strategies. The ProHEpic-19 cohort provides a fine-grained description of the kinetics of antibodies after SARS-CoV-2 infection with an exceptional resolution over 17 months.&lt;h4>Methods&lt;/h4>We established a cohort of 769 healthcare workers including healthy and infected with SARS-CoV-2 in northern Barcelona to determine the kinetics of the IgM against the nucleocapsid (N) and the IgG against the N and spike (S) of SARS-CoV-2 in infected healthcare workers. The study period was from 5 May 2020 to 11 November 2021.We used non-linear mixed models to investigate the kinetics of IgG and IgM measured at nine time points over 17 months from the date of diagnosis. The model</pubmed_abstract><journal>BMC infectious diseases</journal><pubmed_title>Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.</pubmed_title><pmcid>PMC9439943</pmcid><funding_grant_id>Call COVID19-PoC SLT16_04</funding_grant_id><pubmed_authors>Pujol A</pubmed_authors><pubmed_authors>de Osaba JBM</pubmed_authors><pubmed_authors>Caceres EMM</pubmed_authors><pubmed_authors>Iglesias IA</pubmed_authors><pubmed_authors>Bonet JM</pubmed_authors><pubmed_authors>Moyano EJ</pubmed_authors><pubmed_authors>Manresa-Dominguez JM</pubmed_authors><pubmed_authors>Palma AN</pubmed_authors><pubmed_authors>Lamonja-Vicente N</pubmed_authors><pubmed_authors>Chacon C</pubmed_authors><pubmed_authors>Segura EG</pubmed_authors><pubmed_authors>Garcia-Sierra R</pubmed_authors><pubmed_authors>Ortega EO</pubmed_authors><pubmed_authors>Monteagudo M</pubmed_authors><pubmed_authors>Rivas GF</pubmed_authors><pubmed_authors>Violan C</pubmed_authors><pubmed_authors>Moreno-Millan N</pubmed_authors><pubmed_authors>Perich EB</pubmed_authors><pubmed_authors>Kielpilanen A</pubmed_authors><pubmed_authors>Costa MA</pubmed_authors><pubmed_authors>Cintas VS</pubmed_authors><pubmed_authors>Lombarte OB</pubmed_authors><pubmed_authors>Gabriel EM</pubmed_authors><pubmed_authors>Martinez AL</pubmed_authors><pubmed_authors>Lozano FR</pubmed_authors><pubmed_authors>Prat N</pubmed_authors><pubmed_authors>Clotet B</pubmed_authors><pubmed_authors>Dacosta-Aguayo R</pubmed_authors><pubmed_authors>Gonzalez MJA</pubmed_authors><pubmed_authors>ProHEpiC-19 study</pubmed_authors><pubmed_authors>Carabelli J</pubmed_authors><pubmed_authors>Dolade M</pubmed_authors><pubmed_authors>Roca AO</pubmed_authors><pubmed_authors>Toran-Monserrat P</pubmed_authors><pubmed_authors>Armestar F</pubmed_authors><pubmed_authors>Ramos-Roure F</pubmed_authors><pubmed_authors>Rodriguez MP</pubmed_authors><pubmed_authors>Prado JG</pubmed_authors><pubmed_authors>Garcia MS</pubmed_authors><pubmed_authors>Ouchi D</pubmed_authors><pubmed_authors>Carrasco-Ribelles LA</pubmed_authors><pubmed_authors>Roso-Llorach A</pubmed_authors><pubmed_authors>Roldan EM</pubmed_authors><pubmed_authors>Varas EL</pubmed_authors><pubmed_authors>Aguilar JM</pubmed_authors><pubmed_authors>Blanco I</pubmed_authors><pubmed_authors>Duran AV</pubmed_authors><pubmed_authors>Caballero RP</pubmed_authors><pubmed_authors>Espinoza MS</pubmed_authors><pubmed_authors>de San Jose MM</pubmed_authors><pubmed_authors>Rosa LB</pubmed_authors><pubmed_authors>Trigo LT</pubmed_authors><pubmed_authors>Boigues-Pons M</pubmed_authors><pubmed_authors>Palacios-Fernandez C</pubmed_authors><pubmed_authors>Cano CP</pubmed_authors><pubmed_authors>Pradells AD</pubmed_authors><pubmed_authors>Camacho AP</pubmed_authors><pubmed_authors>Devesa MB</pubmed_authors><pubmed_authors>Graells ED</pubmed_authors><pubmed_authors>Poderos RP</pubmed_authors><pubmed_authors>Quirant B</pubmed_authors><pubmed_authors>Montero-Alia P</pubmed_authors><pubmed_authors>Abos SM</pubmed_authors><pubmed_authors>Lopez MAM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.</name><description>&lt;h4>Background&lt;/h4>Understanding the immune response to the SARS-CoV-2 virus is critical for efficient monitoring and control strategies. The ProHEpic-19 cohort provides a fine-grained description of the kinetics of antibodies after SARS-CoV-2 infection with an exceptional resolution over 17 months.&lt;h4>Methods&lt;/h4>We established a cohort of 769 healthcare workers including healthy and infected with SARS-CoV-2 in northern Barcelona to determine the kinetics of the IgM against the nucleocapsid (N) and the IgG against the N and spike (S) of SARS-CoV-2 in infected healthcare workers. The study period was from 5 May 2020 to 11 November 2021.We used non-linear mixed models to investigate the kinetics of IgG and IgM measured at nine time points over 17 months from the date of diagnosis. The model</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-07-14T15:56:52.19Z</modification><creation>2025-02-19T04:03:10.571Z</creation></dates><accession>S-EPMC9439943</accession><cross_references><pubmed>36057544</pubmed><doi>10.1186/s12879-022-07696-6</doi></cross_references></HashMap>